Ovid Therapeutics Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ovid Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
  • Ovid Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$14M, a 24.5% decline year-over-year.
  • Ovid Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$32.5M, a 33% increase year-over-year.
  • Ovid Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$52.3M, a 3.38% increase from 2022.
  • Ovid Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$54.2M, a 144% decline from 2021.
  • Ovid Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $123M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$52.3M +$1.83M +3.38% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 -$54.2M -$177M -144% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $123M +$204M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-13
2020 -$81M -$20.6M -34% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$60.5M -$8.48M -16.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 -$52M +$12.8M +19.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 -$64.8M -$42.4M -189% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 -$22.4M -$9.25M -70.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 -$13.2M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.